Results
91
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
91 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.26 | -5.3% | -0.2% | SEK 341.7m | SEK 2.20 | PS3x | E86.1% | n/a | Tech | ||
YUBICO | SEK 253.00 | -8.8% | 151.5% | SEK 21.8b | SEK 296.67 | PE112.4x | E42.5% | n/a | Software | ||
TRUE B | SEK 34.68 | -0.6% | -7.0% | SEK 11.9b | SEK 57.20 | PE25x | E21.6% | 1.2% | Software | ||
CTT | SEK 271.00 | -2.9% | 18.3% | SEK 3.4b | n/a | PE33.3x | E24.8% | 2.0% | Capital Goods | ||
MAGLE | SEK 37.60 | -2.6% | 20.5% | SEK 406.1m | SEK 50.00 | PE52.8x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
FNOX | SEK 58.44 | 1.3% | 6.6% | SEK 35.6b | SEK 77.88 | PE54.8x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 182.00 | 10.9% | -40.6% | SEK 16.1b | SEK 290.60 | PS53.7x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.60 | -0.6% | -65.0% | SEK 218.6m | SEK 7.90 | PS30x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.39 | 7.2% | -2.4% | SEK 258.5m | SEK 2.84 | PS2.4x | E115.5% | n/a | Tech | ||
CRAD B | SEK 41.35 | -0.5% | 33.4% | SEK 1.4b | SEK 57.00 | PE25.9x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.25 | 6.2% | -9.7% | SEK 318.9m | SEK 3.00 | PS2.3x | E109.0% | n/a | Materials | ||
CTM | SEK 7.22 | -1.0% | -62.3% | SEK 546.2m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
ESGR B | SEK 27.80 | -4.8% | -51.1% | SEK 183.1m | SEK 58.00 | PS1x | E56.6% | n/a | Household | ||
FLEXQ | SEK 10.25 | -4.7% | -41.1% | SEK 137.4m | SEK 25.00 | PS1.2x | E118.7% | n/a | Capital Goods | ||
SENZA | SEK 7.50 | -2.0% | -12.4% | SEK 221.3m | SEK 16.00 | PS4x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.49 | 8.9% | -19.7% | SEK 63.6m | SEK 1.00 | PB3.1x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 317.30 | -6.7% | 46.8% | SEK 374.8b | SEK 354.83 | PE109x | E35.9% | 1.1% | Diversified Financials | ||
4C | SEK 15.45 | -3.4% | -34.8% | SEK 542.8m | SEK 22.00 | PS1.9x | E108.0% | n/a | Software | ||
RUSTA | SEK 66.60 | -10.2% | n/a | SEK 10.1b | SEK 86.00 | PE24.7x | E22.2% | 1.7% | Retail | ||
EGTX | SEK 5.61 | -3.3% | 37.7% | SEK 1.6b | SEK 11.40 | PS23.2x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.49 | 11.4% | -44.1% | SEK 182.8m | n/a | PS2x | E66.8% | n/a | Software | ||
LIME | SEK 313.00 | -2.5% | 14.2% | SEK 4.2b | SEK 353.33 | PE48.4x | E24.1% | 1.1% | Software | ||
RAIL | SEK 30.30 | 2.4% | 66.9% | SEK 731.0m | SEK 34.00 | PE16.7x | E27.0% | 2.3% | Transportation |